dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· March 11, 2026

Bird Reports 2025 Fourth Quarter Results; $11 Billion Combined Backlog and Pending Backlog

View original at globenewswire.com
Bird Reports 2025 Fourth Quarter Results; $11 Billion Combined Backlog and Pending Backlog MISSISSAUGA, Ontario, March 11, 2026 (GLOBE NEWSWIRE) -- “In 2025, Bird successfully navigated near‑term revenue timing shifts while continuing to progress margins and strengthen the business…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Bird successfully navigated near-term revenue timing shifts while continuing to progress margins and strengthen the business in 2025

    60% confidence
  • Bird's risk-balanced combined backlog reflects higher margins than a year ago, giving confidence in achieving growth and further profitability enhancement in 2026 and 2027

    60% confidence
  • Revenue for Q4 2025 was lower than 2024 driven by ongoing impact of previously disclosed delays in start of certain contracted projects

    60% confidence
  • The sole project for the customer with impaired receivables is substantially complete and no further costs are expected to be incurred

    60% confidence
  • Strong demand across key strategic sectors drove record combined backlog with accretive embedded margins, providing historic levels of forward visibility into revenue and earnings growth

    60% confidence
  • Bird remains strongly positioned for Canada's long-duration nation-building investment cycle, including large-scale capital investment energy projects such as LNG and nuclear, as well as infrastructure renewal across defence, healthcare, transportation and trade

    60% confidence
  • With record liquidity and a strong balance sheet, Bird enters 2026 with flexibility, visibility, and momentum

    60% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Bird Reports 2025 Fourth Quarter Results; $11 Billion Combined Backlog and Pending Backlog: Source | Via News | fr.via.news